4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide
C12H15N5O2 — CID 135936842
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide
4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide (PubChem CID 135936842) has the molecular formula C12H15N5O2 and a molecular weight of 261.29 g/mol. Its IUPAC name is 4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide.
Molecular Properties
| Compound Name | 4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide |
|---|---|
| PubChem CID | 135936842 |
| Molecular Formula | C12H15N5O2 |
| Molecular Weight | 261.29 g/mol |
| Exact Mass | 261.12 |
| IUPAC Name | 4-amino-N-hydroxy-N'-(3-propan-2-ylphenyl)-1,2,5-oxadiazole-3-carboximidamide |
| SMILES | CC(C)c1cccc(/N=C(\NO)c2nonc2N)c1 |
| InChI | InChI=1S/C12H15N5O2/c1-7(2)8-4-3-5-9(6-8)14-12(15-18)10-11(13)17-19-16-10/h3-7,18H,1-2H3,(H2,13,17)(H,14,15) |
| InChIKey | MHDAOJWVQGRNDF-UHFFFAOYSA-N |
| XLogP | 1.83 |
| TPSA | 109.56 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 261.29 |
| LogP ≤ 5 | 1.83 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135936842 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.